Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05753683 · ClinicalTrials.gov registry record · NA
Gathering Online for Dialogue and Discussion to Enhance Social Support
A NA study of HIV and Pre-exposure Prophylaxis, sponsored by RTI International.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05753683: Recruiting NA study of HIV and Pre-exposure Prophylaxis, sponsored by RTI International.
NCT05753683 is a NA study of HIV and Pre-exposure Prophylaxis that is actively recruiting participants, run by RTI International. The registered enrollment target is 500 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05753683, a NA study of HIV and Pre-exposure Prophylaxis, is actively recruiting participants, sponsored by RTI International.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with 500 young African American women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol. The expected outcomes are to: (1) determine the efficacy of the virtual group component in reducing alcohol use and sexual risk and increasing pre-exposure prophylaxis (PrEP) utilization; and (2) understand selected outcomes for implementation. Participants will be randomized to receive either the mHealth app or the mHealth app plus the group component, and followed up at 3- and 6-months post-enrollment.
Primary Outcome
Recent alcohol (last 10 days) use will be measured by the presence of ethyl glucuronide (EtG), a breakdown product of ethanol, using an ethyl glucuronide (EtG) urine test. The One Step Ethyl Glucuronide (EtG) Test Dip Card is a lateral flow chromatographic immunoassay. Each test has a control line region to serve as a procedural control and a test line region; results with only a line in the control region and without a line in the test region are classified as positive. Urine EtG ≥300 ng/mL ind
Conditions Studied
Interventions
- BEHAVIORAL mHealth-Women's CoOp
- BEHAVIORAL Virtual Group
Study Locations (1)
North Carolina
- RTI International - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT05753683 shows while recruiting
NCT05753683 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 438-participant average among 303 other HIV trials with a reported enrollment target (14% higher).
The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which mHealth-Women's CoOp is the first listed.
NCT05753683 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05753683 about?
NCT05753683 is a clinical study titled "Gathering Online for Dialogue and Discussion to Enhance Social Support". The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with 500 young African American women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol. The expected outc...
What is the current status of trial NCT05753683?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-04-07. Estimated completion is 2027-04.
What conditions does trial NCT05753683 study?
This clinical trial studies the following conditions: HIV, Pre-exposure Prophylaxis, Sexually Transmitted Infections, Alcohol Misuse.
What interventions are being tested in trial NCT05753683?
The interventions under investigation include: mHealth-Women's CoOp (BEHAVIORAL), Virtual Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05753683?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05753683 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05753683's enrollment target sits among peer trials
500 35th of 303 higher than 269 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI